Protein kinases as targets for anticancer agents: from inhibitors to useful drugs
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 93 (2-3) , 79-98
- https://doi.org/10.1016/s0163-7258(02)00179-1
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Initial sequencing and analysis of the human genomeNature, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Inhibition of Cyclin-Dependent Kinase 4 (Cdk4) by Fascaplysin, a Marine Natural ProductBiochemical and Biophysical Research Communications, 2000
- Cyclin-dependent kinase inhibitors: novel anticancer agentsExpert Opinion on Investigational Drugs, 2000
- The Hallmarks of CancerCell, 2000
- Characterization of Novel Inhibitors of Cyclin-Dependent KinasesBiochemical and Biophysical Research Communications, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Cancer Cell CyclesScience, 1996
- Phenylamino‐Pyrimidine (PAP) Derivatives: A New Class of Potent and Selective Inhibitors of Protein Kinase C (PKC)Archiv der Pharmazie, 1996